Respiratory: clinical-trial pipeline
29,524 respiratory trials are in ClinicalTrials.gov and the EU CTIS portal; 5,276 are not yet finished and 445 of those are in phase 2/3 or 3. Source: Arcadium Data, data as of .
Open trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 3,701 |
| Phase 2 | 500 |
| Phase 3 | 393 |
| Phase 4 | 277 |
| Phase 1 | 179 |
| Phase 1/2 | 129 |
| Phase 2/3 | 52 |
| Early phase 1 | 44 |
| Not stated | 1 |
Sponsors with the most open trials
Recently changed open trials
| Registry id | Title | Sponsor | Phase | Status | Countries |
|---|---|---|---|---|---|
| NCT06052267 | A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preve… | Teva Branded Pharmaceutical Products R&D LLC | Phase 3 | Active, not recruiting | Argentina, Australia, Bulgaria, Canada +18 |
| NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | UMC Utrecht | Phase 3 | Active, not recruiting | Australia, Belgium, Canada, Switzerland +25 |
| NCT05865743 | Perioperative SDD to Prevent Infectious Complications After Esophagectomy | Radboud University Medical Center | Phase 3 | Recruiting | Belgium, Netherlands |
| NCT04614103 | Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | Iovance Biotherapeutics, Inc. | Phase 2 | Not yet recruiting | Australia, Belgium, Canada, Switzerland +9 |
| 2024-512641-16-00 | “Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in mechanically ventilated patients wi… | Rigshospitalet | Phase 2 | Recruiting | Denmark |
| NCT05462717 | Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant So… | Revolution Medicines, Inc. | Phase 1 | Active, not recruiting | Australia, Czechia, Spain, France +9 |
| NCT04157348 | Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab. | AstraZeneca | Phase 3 | Active, not recruiting | Belgium, Canada, Germany, France +5 |
| 2023-503316-33-00 | tislelizUMaB in canceR patients with molEcuLar residuaL disease (UMBRELLA) | Institut Gustave Roussy | Phase 3 | Recruiting | France |
| NCT06523959 | Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial | Clinical Urology and Epidemiology Working Group | Phase 4 | Recruiting | Finland |
| NCT06195540 | RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing | University Hospital, Angers | Phase 3 | Recruiting | France |
| NCT05444699 | Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age | University of Oulu | Phase 4 | Recruiting | Finland |
| NCT03157128 | A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tum… | Eli Lilly and Company | Phase 1/2 | Active, not recruiting | Australia, Canada, Switzerland, Germany +12 |
| NCT06238622 | A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took P… | Boehringer Ingelheim | Phase 3 | Active, not recruiting | Argentina, Austria, Australia, Belgium +39 |
| NCT04245514 | Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) | Swiss Cancer Institute | Phase 2 | Active, not recruiting | Switzerland, Germany |
| 2023-509178-44-00 | Avian and seasonal influenza vaccine induced immune responses | Finnish Institute For Health And Welfare | Phase 4 | Recruiting | Finland |
| NCT05631249 | Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 | Active, not recruiting | France |
| NCT03825835 | 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants | University of Alberta | Not applicable | Active, not recruiting | Canada, Ireland |
| NCT05507242 | Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers i… | Region Hovedstaden | Phase 2 | Recruiting | Denmark, United Kingdom |
| 2023-509503-33-00 | Randomized and controlled clinical trial of the efficacy and safety of the use of lidocaine and magnesium sul… | Clinica Universidad De Navarra | Phase 4 | Not yet recruiting | Spain |
| NCT06041386 | REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN,… | GlaxoSmithKline | Phase 4 | Active, not recruiting | Belgium, Canada, Germany, Spain +5 |
All areas: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Respiratory clinical trials: 5,276 open, 445 in phase 3", https://arcadiumdata.io/clinical-trials/area/respiratory/, data as of 2026-10-25.